AB
Director Pre-clincal Biology
Get the full picture
Sign in to uncover key details.
Ischemix
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
13 Pullard Rd Unit 39, Grafton, Massachu...Phone Number
(508) 839-2999Website
www.ischemix.comRevenue
<$5 MillionIndustry
About Ischemix
Ischemix, Inc. specializes in developing novel cytoprotective compounds, particularly targeting serious diseases. Their lead product candidate, CMX-2043, is currently in preclinical development for traumatic brain injury (TBI) and has shown promising results in various preclinical studies. The company focuses on expanding the therapeutic applications of CMX-2043, which possesses multi-modal activity effective for complex TBI conditions. Ischemix holds several patents related to the composition and usage of CMX-2043 worldwide.Explore more
Ischemix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Ischemix
Compare insights from companies similar to Ischemix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ischemix Tech Stack
A closer look at the technologies used by Ischemix
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ischemix
Sign Up For FreeTo access detailed company insights
Ischemix, Inc. specializes in developing novel cytoprotective compounds, particularly targeting serious diseases. Their lead product candidate, CMX-2043, is currently in preclinical development for traumatic brain injury (TBI) and has shown promising results in various preclinical studies. The company focuses on expanding the therapeutic applicatio... Read More
